Lumigan and Benicar drug interactions - from FDA reports


Drug interactions are reported among people who take Lumigan and Benicar together. This study is created by eHealthMe based on reports of 91 people who take Lumigan and Benicar from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jan, 06, 2019

91 people who take Lumigan, Benicar are studied.


Number of reports submitted per year:

Lumigan and Benicar drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Dry eye (lack of adequate tears)
  2. Dry mouth
  3. Eye irritation
  4. Eye pain
  5. Foreign body sensation in eyes (feeling of something in eye)
  6. Therapeutic response decreased (less preventive response)
1 - 6 months:
  1. Colitis ulcerative (inflammation of colon with ulcer)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  4. Renal cyst (kidney cyst)
  5. Gastrointestinal tract adenoma (a benign tumour (-oma) of glandular origin in digestive tract)
  6. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:
  1. Constipation
  2. Drug administration error
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Haematochezia (passage of stools containing blood)
  5. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Renal cyst (kidney cyst)
  8. Coeliac disease (simple food intolerance)
  9. Duodenal ulcer
  10. Gastritis haemorrhagic (inflammation of stomach with bleeding)
10+ years:
  1. Alopecia (absence of hair from areas of the body)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Psychological trauma
not specified:
  1. Hypokalaemia (low potassium)
  2. Intraocular pressure increased
  3. Orthopnoea (shortness of breath (dyspnea) when lying down)
  4. Red blood cell count decreased
  5. Vomiting
  6. White blood cell count decreased
  7. Gastroenteritis (inflammation of stomach and intestine)
  8. Oedema (fluid collection in tissue)
  9. Abdominal pain
  10. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)

Most common drug interactions by gender *:

female:
  1. Adverse event
  2. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  3. Blood alkaline phosphatase increased
  4. Electrocardiogram poor r-wave progression
  5. Fatigue (feeling of tiredness)
  6. Fluid retention (an abnormal accumulation of fluid in the blood)
  7. Gastroenteritis (inflammation of stomach and intestine)
  8. Haemorrhage (bleeding)
  9. Headache (pain in head)
  10. Hot flush (sudden feelings of heat)
male:
  1. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  2. Renal cyst (kidney cyst)
  3. Pneumonia
  4. Retinal dystrophy (progressive weakness and wasting of the retina)
  5. Tinnitus (a ringing in the ears)
  6. Visual acuity reduced (reduced clearness of vision)
  7. Constipation
  8. Drug administration error
  9. Gastroenteritis (inflammation of stomach and intestine)
  10. Haematochezia (passage of stools containing blood)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:
  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Atrioventricular block complete (heart block complete)
  3. Pain
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Anxiety
  6. Chest pain
  7. Multiple injuries
  8. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  9. Renal failure acute (rapid kidney dysfunction)
  10. Therapeutic agent toxicity (poisoning by ability to cure substance)
60+:
  1. Blindness
  2. Blindness unilateral
  3. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  4. C-reactive protein increased
  5. Fatigue (feeling of tiredness)
  6. Feeling hot
  7. Femur fracture
  8. Flushing (the warm, red condition of human skin)
  9. Fracture displacement
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you take Lumigan and Benicar?


You are not alone:




Related studies

Lumigan

Lumigan has active ingredients of bimatoprost. It is often used in glaucoma. (latest outcomes from Lumigan 10,309 users)

Benicar

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. (latest outcomes from Benicar 27,591 users)


Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Lumigan and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Benicar and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Lumigan and Benicar
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Lumigan and Benicar

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!